Evolus (NASDAQ:EOLS – Get Rating) had its price target upped by HC Wainwright from $15.00 to $16.00 in a research note published on Wednesday, The Fly reports. Several other equities analysts have also commented on EOLS. Needham & Company LLC reaffirmed a buy rating and issued a $18.00 price target on shares of Evolus in […]
Related Keywords
Hong Kong , Scott Cannizzaro , David Moatazedi , Life Insurance Co , Ensign Peak Advisors Inc , Hong Kong Ltd , Needham Company , Tower Research Capital , Evolus Inc , Get Rating , Kong Ltd , Research Capital , Newport Beach , Evolus Daily , Evolus , Nasdaq Eols , Deols , Medical , Boost Price Target , Hc Wainwright ,
comparemela.com © 2020. All Rights Reserved.